Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment


               of Certain Officers; Compensatory Arrangements of Certain Officers.


Appointment of Executive Officer
On and effective as of January 11, 2021, the Board of Directors of Sabra Health
Care REIT, Inc., a Maryland corporation (the "Company"), appointed Michael Costa
to serve as Executive Vice President - Finance and Chief Accounting Officer
until his successor is duly elected and qualifies. In this position, Mr. Costa
will serve as the Company's Principal Accounting Officer. Mr. Costa, age 42,
currently serves as the Company's Executive Vice President - Finance, a position
he has held since August 2017. Previously, Mr. Costa held various leadership
positions overseeing the Company's accounting and finance functions since
Sabra's inception in November 2010.
In connection with his appointment as Chief Accounting Officer, Mr. Costa's
annual base salary will be increased from $340,704 to $400,000. There are no
arrangements or understandings between Mr. Costa and any other person pursuant
to which Mr. Costa was appointed as Executive Vice President - Finance and Chief
Accounting Officer, and there are no transactions in which Mr. Costa has an
interest that would require disclosure under Item 404(a) of Regulation S-K. No
family relationship exists between Mr. Costa and any director or other executive
officer of the Company.
Appointment of Director
On and effective as of January 11, 2021, the Company's Board of Directors
increased the size of the Company's Board of Directors from ten to eleven
directors and appointed Katie Cusack to serve as a member of the Board of
Directors until the Company's 2021 Annual Meeting of Stockholders and until her
successor is duly elected and qualifies.
As a non-employee director, Ms. Cusack will receive compensation in the same
manner as the Company's other non-employee directors, in accordance with the
Company's Directors' Compensation Policy, which is attached as Exhibit 10.9 to
the Company's Annual Report on Form 10-K for the year ended December 31, 2019,
filed with the Securities and Exchange Commission on February 24, 2020, which
exhibit is incorporated herein by this reference.
There is no arrangement or understanding between Ms. Cusack and any other
persons pursuant to which Ms. Cusack was appointed as a director, and Ms. Cusack
has no direct or indirect material interest in any transaction required to be
disclosed pursuant to Item 404(a) of Regulation S-K.
Item 7.01   Regulation FD Disclosure

On January 12, 2021, the Company issued press releases announcing the appointment of Mr. Costa as Executive Vice President - Finance and Chief Accounting Officer and the appointment of Ms. Cusack to the Board of Directors, as set forth in Item 5.02 of this Current Report on Form 8-K. Copies of the press releases regarding the appointments of Mr. Costa and Ms. Cusack are furnished as Exhibit 99.1 and Exhibit 99.2, respectively, hereto. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in any such filing. Item 9.01 Financial Statements and Exhibits




(d)               Exhibits.

99.1                Press Release dated January 12, 2021.

99.2                Press Release dated January 12, 2021.

104               Cover Page Interactive Data File (embedded within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses